What is the equity of Camurus this year?
Camurus has equity of 1.49 B SEK this year.
Camurus Equity 2024
Camurus Equity
1.49 B SEK
Ticker
CAMX.ST
ISIN
SE0007692850
WKN
A2ABG7
In 2024, Camurus's equity was 1.49 B SEK, a 50.1% increase from the 994.67 M SEK equity in the previous year.
Camurus Aktienanalyse
What does Camurus do?
Camurus AB is a Swedish biopharmaceutical company that specializes in the development of innovative medications for the treatment of serious diseases. The company was founded in 1991 by an interdisciplinary team of chemists, biologists, and drug developers and is headquartered in Lund, Sweden. Camurus AB specializes in the development of medications based on long-acting drug release technology. This technology allows medications to be administered in a very precise manner and over a longer period of time. This enables the benefits of a constant drug concentration in the blood to be utilized without requiring multiple doses per day. The core business of Camurus AB includes the development of medications for the treatment of pain, cancer, and addiction. The company works closely with clients, partners, and academic institutions to bring innovative medications to market that can have a significant impact on patients' lives. One of Camurus AB's key areas is pain therapy. The company has developed a novel technology that allows pain medications to be administered in the form of sprays and patches. This technology is based on the release of buprenorphine, a potent painkiller that previously could only be administered as repeated single doses or in the form of an implant due to its short half-life. The extended release allows for a sustained high concentration of the drug in the blood, without the need for the patient to take multiple single doses. Camurus AB is also active in oncology and has developed medications for the treatment of breast and prostate cancer that also utilize long-acting drug release. These medications help patients better tolerate the side effects of chemotherapy and improve their quality of life. Another important area for Camurus AB is addiction therapy. The company has developed a medication based on buprenorphine for the treatment of opioid dependence. This medication activates the body's own opioid receptors and reduces the cravings for further drugs. In recent years, Camurus AB has introduced several important products to the market and holds a wide portfolio of patents and protective rights. The company is committed to improving patient care and making global healthcare a better and more effective system. In conclusion, Camurus AB is an innovative biopharmaceutical company specializing in the development of medications for the treatment of pain, cancer, and addiction. The company is dedicated to improving global healthcare and works closely with clients, partners, and academic institutions to develop innovative, effective, and patient-oriented solutions. Camurus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Camurus's Equity
Camurus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Camurus's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Camurus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Camurus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Camurus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Camurus stock
What was the equity of Camurus compared to the previous year?
The equity of Camurus has increased/decreased by 50.1% increased compared to the previous year.
What impact does a high equity have on investors of Camurus?
A high equity is advantageous for investors of Camurus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Camurus?
A low equity can be a risk for investors of Camurus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Camurus affect the company?
An increase in equity of Camurus can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Camurus affect the company?
A reduction in equity of Camurus can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Camurus?
Some factors that can affect the equity of Camurus include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Camurus so important for investors?
The equity of Camurus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Camurus take to change the equity?
To change equity, Camurus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Camurus pay?
Over the past 12 months, Camurus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Camurus is expected to pay a dividend of 0 SEK.
What is the dividend yield of Camurus?
The current dividend yield of Camurus is .
When does Camurus pay dividends?
Camurus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Camurus?
Camurus paid dividends every year for the past 0 years.
What is the dividend of Camurus?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Camurus located?
Camurus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Camurus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Camurus from 9/13/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Camurus pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Camurus in the year 2023?
In the year 2023, Camurus distributed 0 SEK as dividends.
In which currency does Camurus pay out the dividend?
The dividends of Camurus are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Camurus
Our stock analysis for Camurus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Camurus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
